Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 10Sarcoma 7Genitourinary 7Gastrointestinal 5Thoracic 3Lymphoid 3Dermatologic 3Plasma cell 2Other hematologic neoplasm 2Myeloid 2Head & Neck 2Other solid neoplasm 1NET 1Gynecologic 1Endocrine 1

Conditions

Leukemia, Myeloid, Acute 441Precursor Cell Lymphoblastic Leukemia-Lymphoma 242Hematologic Neoplasms 220Leukemia, Lymphocytic, Chronic, B-Cell 186Myelodysplastic Syndromes 162Leukemia 131Lymphoma 92Lymphoma, Non-Hodgkin 82Leukemia, Myelogenous, Chronic, BCR-ABL Positive 73Multiple Myeloma 69Recurrence 59Leukemia, Myelomonocytic, Chronic 58Neoplasms 54Leukemia, Biphenotypic, Acute 48Burkitt Lymphoma 48Myeloproliferative Disorders 46Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 43Lymphoma, Large B-Cell, Diffuse 43Lymphoma, Mantle-Cell 41Hodgkin Disease 39Lymphoma, Follicular 34Lymphoma, B-Cell 33Lymphoma, B-Cell, Marginal Zone 27Leukemia, B-Cell 27Waldenstrom Macroglobulinemia 26Anemia, Refractory, with Excess of Blasts 25Primary Myelofibrosis 24Myelodysplastic-Myeloproliferative Diseases 21Leukemia, Myeloid, Chronic-Phase 19Hematologic Diseases 19

Interventions

fludarabine phosphate 1fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms, Germ Cell and Embryonal × Other hematologic neoplasm × 90 days × Clear all
NCT05092451 2026-05-06

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
80 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Plasma Cell, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Germ Cell and Embryonal, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell

NCT01890486 2026-04-13

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

Wake Forest University Health Sciences

Recruiting
2,000 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Germ Cell and Embryonal, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡